Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

163 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Safety profile of biological intravenous therapy in a rheumatoid arthritis patients cohort. Clinical nursing monitoring (Sebiol study).
Corominas H, Sánchez-Eslava L, García G, Padró I, Aimarich C, Gonzàlez J, Franco M, Mur E, Sanchez S, Roldán G, Iniesta S, Sesma M, Martín J, Rodriguez MC, Capellan MR, Gosálvez C, Garcia-Diaz S, Sáez E, Luna Y, Plana P. Corominas H, et al. Reumatol Clin. 2013 Mar-Apr;9(2):80-4. doi: 10.1016/j.reuma.2012.06.001. Epub 2012 Oct 24. Reumatol Clin. 2013. PMID: 23099285 Free article. Clinical Trial. English, Spanish.
PDE3A-SLCO1C1 locus is associated with response to anti-tumor necrosis factor therapy in psoriatic arthritis.
Julià A, Rodríguez J, Fernández-Sueiro JL, Gratacós J, Queiró R, Montilla C, Torre-Alonso JC, Pérez-Venegas JJ, Manrique-Arija S, Muñoz-Fernández S, González C, Roig D, Zarco P, Erra A, Castañeda S, García A, Salvador G, Díaz-Torne C, Blanco R, Domínguez AW, Mosquera JA, Vela P, Tornero J, Sánchez-Fernández S, Corominas H, Ramírez J, Avila G, Alonso A, Tortosa R, López-Lasanta M, Cañete JD, Marsal S. Julià A, et al. Among authors: corominas h. Pharmacogenomics. 2014 Nov;15(14):1763-1769. doi: 10.2217/pgs.14.125. Pharmacogenomics. 2014. PMID: 25493569
A deletion at ADAMTS9-MAGI1 locus is associated with psoriatic arthritis risk.
Julià A, Pinto JA, Gratacós J, Queiró R, Ferrándiz C, Fonseca E, Montilla C, Torre-Alonso JC, Puig L, Pérez Venegas JJ, Fernández Nebro A, Fernández E, Muñoz-Fernández S, Daudén E, González C, Roig D, Sánchez Carazo JL, Zarco P, Erra A, López Estebaranz JL, Rodríguez J, Ramírez DM, de la Cueva P, Vanaclocha F, Herrera E, Castañeda S, Rubio E, Salvador G, Díaz-Torné C, Blanco R, Willisch Domínguez A, Mosquera JA, Vela P, Tornero J, Sánchez-Fernández S, Corominas H, Ramírez J, López-Lasanta M, Tortosa R, Palau N, Alonso A, García-Montero AC, Gelpí JL, Codó L, Day K, Absher D, Myers RM, Cañete JD, Marsal S. Julià A, et al. Among authors: corominas h. Ann Rheum Dis. 2015 Oct;74(10):1875-81. doi: 10.1136/annrheumdis-2014-207190. Epub 2015 May 19. Ann Rheum Dis. 2015. PMID: 25990289 Free article.
Diagnostic and therapeutic delay of rheumatoid arthritis and its relationship with health care devices in Catalonia. The AUDIT study.
Corominas H, Narváez J, Díaz-Torné C, Salvador G, Gomez-Caballero ME, de la Fuente D, Campoy E, Roig-Vilaseca D, Clavaguera T, Morlà R, Torrente-Segarra V, Arasa X, Gomez-Puerta JA, Möller I, Alegre C, Graell E, Ponce A, Lisbona MP, Pérez-Garcia C, Fíguls R, Sirvent E, Poca V, Sanmartí R. Corominas H, et al. Reumatol Clin. 2016 May-Jun;12(3):146-50. doi: 10.1016/j.reuma.2015.08.002. Epub 2015 Sep 8. Reumatol Clin. 2016. PMID: 26362843 Free article. English, Spanish.
VARIAR Study: Assessment of short-term efficacy and safety of rituximab compared to an tumor necrosis factor alpha antagonists as second-line drug therapy in patients with rheumatoid arthritis refractory to a first tumor necrosis factor alpha antagonist.
Torrente-Segarra V, Acosta Pereira A, Morla R, Ruiz JM, Clavaguera T, Figuls R, Corominas H, Geli C, Roselló R, de Agustín JJ, Alegre C, Pérez C, García A, Rodríguez de la Serna A. Torrente-Segarra V, et al. Among authors: corominas h. Reumatol Clin. 2016 Nov-Dec;12(6):319-322. doi: 10.1016/j.reuma.2015.11.019. Epub 2016 Jan 29. Reumatol Clin. 2016. PMID: 26831256 Free article. English, Spanish.
Urine metabolome profiling of immune-mediated inflammatory diseases.
Alonso A, Julià A, Vinaixa M, Domènech E, Fernández-Nebro A, Cañete JD, Ferrándiz C, Tornero J, Gisbert JP, Nos P, Casbas AG, Puig L, González-Álvaro I, Pinto-Tasende JA, Blanco R, Rodríguez MA, Beltran A, Correig X, Marsal S; IMID Consortium. Alonso A, et al. BMC Med. 2016 Sep 8;14(1):133. doi: 10.1186/s12916-016-0681-8. BMC Med. 2016. PMID: 27609333 Free PMC article.
Biologic Disease-modifying antirheumatic drug attributes in the first lines of treatment of rheumatoid arthritis. 2015 ACORDAR project.
Muñoz-Fernández S, Bustabad Reyes MS, Calvo Alén J, Castaño Sánchez M, Chamizo Carmona E, Corominas H, Fernández-Llanio Comella N, Hidalgo Calleja MC, Pérez Venegas JJ, Rodríguez Heredia JM, Romero Yuste SM, Ruiz-Esquide Torino V; Grupo de trabajo ACORDAR 2015. Muñoz-Fernández S, et al. Among authors: corominas h. Reumatol Clin (Engl Ed). 2018 Mar-Apr;14(2):90-96. doi: 10.1016/j.reuma.2016.10.001. Epub 2017 Jan 3. Reumatol Clin (Engl Ed). 2018. PMID: 28065486 Free article. English, Spanish.
163 results